Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
All content for FDA Drug Information Updates is the property of ReachMD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
Pinpointing the Top Questions about Biosimilars in Rheumatology
FDA Drug Information Updates
7 years ago
Pinpointing the Top Questions about Biosimilars in Rheumatology
Guest: Leonard H. Calabrese, DO
Guest: John R. Tesser, MD
This activity provides patient and practice-specific biosimilars content for clinicians in rheumatology practice.
FDA Drug Information Updates
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
